๐ Pathophysiology
Chronic inflammation โ oedema, mucus plugging, bronchospasm. Airway obstruction during expiration โ air trapping โ dynamic hyperinflation โ auto-PEEP โ โ venous return, hypotension, barotrauma.
๐ Severity Grades
Mild: SpO2 >94%, normal speech. Acute severe: SpO2 90-94%, sentences to words, use of accessory muscles. Life-threatening: SpO2 <90%, silent chest, altered sensorium, pulsus paradoxus, hypercapnia.
๐ Pharmacotherapy
Continuous nebulised salbutamol + ipratropium, IV steroids (hydrocortisone/methylprednisolone). Magnesium (25-50 mg/kg IV). Ketamine (1-2 mg/kg then infusion) for refractory bronchospasm.
๐ซ Ventilatory Strategy (if intubated)
Low rate (10-12/min), low tidal volume (5-7 mL/kg), prolonged expiratory time (I:E 1:3-1:4), permissive hypercapnia (pH โฅ7.2), set external PEEP at ~2/3 auto-PEEP. Avoid hyperinflation and hypotension.
โ ๏ธ Intubation Indications
Cardiac/respiratory arrest, severe hypoxia, altered sensorium, no improvement despite maximum therapy, rising PaCO2 with acidosis, exhaustion.
๐ Rescue Therapies
Manual chest compression during expiration for severe air trapping. Heliox (80/20) if FiO2 โค0.3. Inhaled anaesthetics (sevoflurane, isoflurane) for refractory status asthmaticus.